ORPHAZYME ANNUAL REPORT 2018 PRESENTATION

Copenhagen, Denmark, February 25, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that the Company will be hosting an investor call at which Chief Executive Officer, Anders Hinsby, and Chief Financial Officer, Anders Vadsholt, will be presenting the Orphazyme Annual Report 2018. The presentation will be followed by a Q&A session.

The call will be held on Friday, March 1, 2019 at 11.00 AM CET.

Dial-in details:

·       Denmark: +45 32 72 80 42

·       France: +33 (0) 176 700 794

·       Netherlands: +31 (0) 207 143 545

·       Sweden: +46 (0) 850 692 180

·       United Kingdom: +44 (0) 844 571 88 92

·       United States: +1 63 15 107 495

Event Title: Orphazyme Annual Report 2018

Confirmation code: 1127327

The presentation will also be available via webcast: https://edge.media-server.com/m6/p/et2opupq

After the call, the presentation will be available via the above link or by using the following dial-in details: 

·       International: +44 (0) 3333009785

·       Confirmation code: 1127327